Market News

Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Equal-Weight and raises the price target from $236 to $252.

As investors rushed out of US technology stocks on Thursday, selling by trend-following systematic strategies amplified what quickly became a record p...

ATLANTA, November 06, 2026--Interface, Inc. (Nasdaq: TILE), the global flooring and sustainability leader, today announced results for the third quart...

SpaceX has been in the spotlight since its historic IPO.

Cigna earns a Buy rating on raised EPS guidance, margin gains, and valuation upside despite PBM pressure. Click here to read an analysis of CI stock n...

CoastalSouth Bancshares delivered robust Q3 results, driven by strong net interest income and non-recurring gains. Discover more on the COSO stock her...

The Federal Reserve has been focusing more on inflation recently, but a strong jobs report for October makes a December rate hike an even easier deci...

Wheaton Precious Metals Corp (LSE:WPM, TSX:WPM, NYSE:WPM) delivered a better-than-expected third quarter, according to Peel Hunt, which retained its '...

South Korea’s equity market was hit hard again, suffering what local media are calling a “Black Friday” collapse overnight.

Wells Fargo analyst Sam Margolin maintains ConocoPhillips (NYSE:COP) with a Overweight and lowers the price target from $189 to $185.

Piper Sandler analyst Thomas Champion reiterates Airbnb (NASDAQ:ABNB) with a Neutral and raises the price target from $170 to $180.

The newly approved projects include two US Midwest pipeline expansions and a second phase ofCoastal GasLink in Canada.

Keybanc analyst Jeffrey D. Hammond maintains Helios Technologies (NYSE:HLIO) with a Overweight and lowers the price target from $95 to $85.

Goldman Sachs BDC (NYSE:GSBD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has be...

Elanco Animal Health (NYSE:ELAN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has...

Piper Sandler analyst David Amsellem reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Neutral and raises the price target from $8 to $12.

Ziff Davis (NASDAQ:ZD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been prov...

Fluor (NYSE:FLR) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided b...

DRAM ETF investors face $7 billion in estimated losses as a 40% plunge rattles the artificial intelligence memory chip trade.